Explore the latest developments in Medicare for 2025 including UnitedHealthcare's market exits, anticipated drug price increases, new rural hospital funding legislation, and changes to Medicare Savings Programs affecting coverage and costs.
Blue Cross Blue Shield Michigan and Blue Care Network promote proactive provider engagement for the 2025 Medicare Advantage Health Outcomes Survey, focusing on incontinence and fall prevention to improve health outcomes.
Explore how initial enrollment in Medicare Advantage plans affects the ability to switch back to original Medicare and obtain Medigap coverage without penalties or underwriting issues.
In 2025, the SSA notified over 850,000 ZIP codes about Medicare programs like Extra Help and Medicare Savings Programs that aid with medical and prescription costs. Many eligible beneficiaries remain unaware of these savings opportunities.
In 2025, the SSA notified over 850,000 ZIP codes about Medicare Extra Help and Medicare Savings Programs, emphasizing eligibility criteria and benefits available to reduce beneficiaries' out-of-pocket costs on prescription drugs and medical expenses.
Analysis shows rising exits of primary care physicians from Medicare fee-for-service, highlighting access challenges for older adults and shifts to Medicare Advantage and direct primary care models.
Maine Senator emphasizes the importance of Medicare Advantage for seniors and disabled Americans, noting a 5% payment increase for 2026 to reverse prior cuts and improve healthcare access, especially in rural areas.
UnitedHealth Group is cooperating with DOJ investigations into its Medicare Advantage practices, emphasizing compliance and initiating third-party reviews. Independent CMS audits and court rulings support UnitedHealth's adherence to Medicare regulations.
ASCs face increasing delays and denials from payers impacting revenue cycles. Increased scrutiny on device/pharma claims and contract carve-outs prompt ASC contract renegotiations amid Medicare Advantage changes.
Starting in 2025, Medicare prescription drug plans will have a new $2,000 out-of-pocket cap under the Inflation Reduction Act, eliminating the donut hole and lowering costs for beneficiaries. This applies to both Part D and Medicare Advantage plans with drug coverage.
